Bell Investment Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15 Sell
1
-3
-75% -$32 ﹤0.01% 1817
2026
Q1
$34 Hold
4
﹤0.01% 1855
2025
Q4
$46 Sell
4
-37
-90% -$458 ﹤0.01% 1797
2025
Q3
$616 Hold
41
﹤0.01% 1697
2025
Q2
$579 Buy
41
+35
+583% +$624 ﹤0.01% 1729
2025
Q1
$145 Hold
6
﹤0.01% 1879
2024
Q4
$225 Hold
6
﹤0.01% 1867
2024
Q3
$300 Hold
6
﹤0.01% 1839
2024
Q2
$209 Hold
6
﹤0.01% 1921
2024
Q1
$329 Hold
6
﹤0.01% 1883
2023
Q4
$257 Sell
6
-3
-33% -$93 ﹤0.01% 1892
2023
Q3
$235 Sell
9
-1
-10% -$21 ﹤0.01% 1897
2023
Q2
$240 Hold
10
﹤0.01% 1902
2023
Q1
$137 Hold
10
﹤0.01% 1904
2022
Q4
$139 Sell
10
-7
-41% -$99 ﹤0.01% 1933
2022
Q3
$3K Buy
+17
New +$123 ﹤0.01% 878

Other funds holding BHVN

Bell Investment Advisors's BHVN Position: Q2 2026 in Review

Bell Investment Advisors reduced its Biohaven (BHVN) stake by 75% in Q2 2026, selling an estimated $32 and leaving 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

Bell Investment Advisors first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $3K in Q3 2022. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Bell Investment Advisors held 1 share of Biohaven worth $15 as of Q2 2026.
  • Bell Investment Advisors sold 3 Biohaven shares in Q2 2026, an estimated $32.
  • Biohaven made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1817 holding.
  • Bell Investment Advisors first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
  • Bell Investment Advisors's Biohaven position peaked at $3K in Q3 2022.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.